The point-of-care testing (POCT) market would grow at a CAGR of 10.92% over the predicted time frame. The market is expected to increase in value from US$ 45.03  Bn in 2022 to US$ 103.2 Bn in 2030.

Key Takeaways:

• North America was accounted highest revenue share more than 46% in 2021.
• Asia Pacific POCT market is registering at a CAGR of 9.8% from 2022 to 2030.
• By product, glucose monitoring products segment has captured highest revenue share 27% in 2021. 
• By platform, lateral flow assays segment has accounted 36% revenue share in 2021.
• By mode of purchase, OTC testing products segment has held 59% revenue share in 2021.
• The glucose monitoring segment was valued at USD 8.91 billion in in 2021.
• The biosensors segment is growing a CAGR of 9.2% during the frorecast period.
• The pregnancy and fertility testing products segment is expected to reach at a 8.1% of CAGR from 2022 to 2030.
• The diagnostic centers segment is growing at a CAGR of 7.8% over the forecast period.

The on point-of-care testing (POCT) Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2270

A recent report provides crucial insights along with application based and forecast information in the Global Point-of-care testing (POCT) Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Point-of-care testing (POCT) market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific Revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Point-of-care testing (POCT) market are included as given below:

Point-of-care testing (POCT) Market Key Players are: Sinocare Inc, Hoffmann La Roche Ltd, Siemens AG, Abott Laboratories, bioMrieux SA, Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC, Mankind pharma, OraSure Technologies, inc, A. Menarini Diagnostics s.r.l, ACON Laboratories, Trinity Biotech plc

Market Segments

By Product Type

• Covid -19 testing kits
• Glucose monitoring products
  • Meters
  • Strips
  • Lancets and Lancing devices
• Cardiometabolic Monitoring Products
  • Cardiac maker testing products
  • Blood Gas / Electrolyte testing products
  • HbA1c testing products
• Infectious disease testing products
  • Influenza testing products
  • HIV testing products
  • Hepatitis testing products
  • Sexually Transmitted Diseases testing products
  • Healthcare - associated Infection testing products
  • Respiratory infection testing products
  • Tropical disease testing products
  • others
• Coagulation monitoring products
  • PT / INR testing
  • ACT / APTT
• Pregnancy and fertility testing products
• Pregnancy testing products
• Fertility testing products
• Cancer marker testing products
• Urinanalysis testing products
• Cholestrol testing products
• Hematology testing products
• Drugs-of-abuse testing products
• Fecal Occult testing products
• Others

By Platform

• Lateral Flow Assays
• Dipsticks
• Microfluids
• Molecular Diagnostics
• Immunoassays

By Mode of Purchase

• OTC products
• Prescribed based products

By Testing Type

• Immunoassays
• Cell-Based Assays
• Nucleic Acid Amplification Testing
• Clinical Chemistry Assays
• Hematology 

By End-User

• Clinical laboratories
• Ambulatory care facilities and physician offices
• Pharmacies, retail clinics & E-comm platforms
• Hospitals, Critical care centres, Urgent care centres
• Home care & self-testing
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Report Objectives

• To define, describe, and forecast the global point-of-care testing (POCT) market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the point-of-care testing (POCT) market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-Care Testing (POCT) Market 

5.1. COVID-19 Landscape: Point-of-Care Testing (POCT) Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-Care Testing (POCT) Market, By Product Type

8.1. Point-of-Care Testing (POCT) Market, by Product Type, 2022-2030

8.1.1. Covid -19 testing kits

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Glucose monitoring products

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Cardiometabolic Monitoring Products

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Infectious disease testing products

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Coagulation monitoring products

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Pregnancy and fertility testing products

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Pregnancy testing products

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Fertility testing products

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Cancer marker testing products

8.1.9.1. Market Revenue and Forecast (2017-2030)

8.1.10. Urinanalysis testing products

8.1.10.1. Market Revenue and Forecast (2017-2030)

8.1.11. Cholestrol testing products

8.1.11.1. Market Revenue and Forecast (2017-2030)

8.1.12. Hematology testing products

8.1.12.1. Market Revenue and Forecast (2017-2030)

8.1.13. Drugs-of-abuse testing products

8.1.13.1. Market Revenue and Forecast (2017-2030)

8.1.14. Fecal Occult testing products

8.1.14.1. Market Revenue and Forecast (2017-2030)

8.1.15. Others

8.1.15.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Point-of-Care Testing (POCT) Market, By Platform

9.1. Point-of-Care Testing (POCT) Market, by Platform, 2022-2030

9.1.1. Lateral Flow Assays

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Dipsticks

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Microfluids

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Molecular Diagnostics

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Immunoassays

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Point-of-Care Testing (POCT) Market, By Mode of Purchase 

10.1. Point-of-Care Testing (POCT) Market, by Mode of Purchase, 2022-2030

10.1.1. OTC products

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Prescribed based products

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Point-of-Care Testing (POCT) Market, By Testing Type

11.1. Point-of-Care Testing (POCT) Market, by Testing Type, 2022-2030

11.1.1. Immunoassays

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Cell-Based Assays

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Nucleic Acid Amplification Testing

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Clinical Chemistry Assays

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Hematology

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Point-of-Care Testing (POCT) Market, By End-User

12.1. Point-of-Care Testing (POCT) Market, by End-User, 2022-2030

12.1.1. Clinical laboratories

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Ambulatory care facilities and physician offices

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Pharmacies, retail clinics & E-comm platforms

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Hospitals, Critical care centres, Urgent care centres

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Home care & self-testing

12.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Point-of-Care Testing (POCT) Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Platform (2017-2030)

13.1.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.1.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.1.5. Market Revenue and Forecast, by End-User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Platform (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End-User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.4. Market Revenue and Forecast, by Testing Type (2017-2030) 

13.2.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.7. Market Revenue and Forecast, by Testing Type (2017-2030) 

13.2.8. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.10. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.11. Market Revenue and Forecast, by End-User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.13. Market Revenue and Forecast, by End-User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.15. Market Revenue and Forecast, by End-User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.7. Market Revenue and Forecast, by End-User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.9. Market Revenue and Forecast, by End-User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.7. Market Revenue and Forecast, by End-User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.9. Market Revenue and Forecast, by End-User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Platform (2017-2030)

13.5.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.5.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.5.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.5.7. Market Revenue and Forecast, by End-User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Platform (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 14. Company Profiles

14.1. Sinocare Inc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Hoffmann La Roche Ltd

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Siemens AG

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Abott Laboratories

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. bioMrieux SA

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Becton Dickinson and Company

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Danaher Coraporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Nova Biomedical

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9.Sysmex corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Johnson and Johnson

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: [email protected]

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com